de Cates Angharad N, Farr Matthew Rb, Rees Karen, Casas Juan P, Huffman Mark
Division of Health Sciences, Warwick Medical School, University of Warwick, Coventry, UK.
Department of Non-communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine; Department of Epidemiology and Public Health, University College London, London, UK.
Cochrane Database Syst Rev. 2012(5). doi: 10.1002/14651858.CD009868.
This is the protocol for a review and there is no abstract. The objectives are as follows: To determine the effectiveness of fixed-dose combination therapy on optimising CVD risk factors and reducing CVD fatal and non-fatal events for both primary and secondary prevention of CVD. Details of CVD events and risk factors included are listed in the methods. We will also determine any adverse events associated with taking fixed-dose combination therapy. This will include studies conducted in both developed and developing regions of the world.
这是一项综述的方案,没有摘要。目标如下:确定固定剂量联合疗法在优化心血管疾病(CVD)危险因素以及降低CVD致命和非致命事件方面对CVD一级和二级预防的有效性。方法部分列出了所纳入的CVD事件和危险因素的详细信息。我们还将确定与服用固定剂量联合疗法相关的任何不良事件。这将包括在世界发达地区和发展中地区开展的研究。